CEFZIL® for Oral Suspension 250 mg/5mL

DRUG2 trials

Sponsors

Teva Pharmaceuticals USA

Conditions

Healthy

Phase 1

Cefprozil for Oral Suspension 250 mg/5 mL, Fasting

CompletedNCT00835614

Teva Pharmaceuticals USAHealthy

Start: 2004-04-30End: 2004-04-30Updated: 2024-08-20

Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting

CompletedNCT00835354

Teva Pharmaceuticals USAHealthy

Start: 2004-05-31End: 2004-05-31Updated: 2024-08-20